Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
April 26th, 2023
ICAS Announces Winners of the 2023 Global Awards and Launches New Diversity, Equity and Inclusion Award Category
Advertising Partner Jeffrey A. Greenbaum chaired a jury of experts at the International Council for Advertising Self-Regulation’s (ICAS) Global Awards Ceremony at the Feriye Palace in Istanbul, Turkey. The objective of the ICAS Awards is to reward initiatives that contribute to responsible marketing practices and a more effective and impactful self-regulatory system. Jeff is quoted saying, “Advertising self-regulatory organizations around the world are doing incredible, ground-breaking work that is truly making a difference. This year’s winners of the ICAS Awards represent the best-of-the best. The work that we are so thrilled to be celebrating demonstrates how self-regulation can quickly and effectively – often with very limited resources – address, in a very impactful way, many of the most pressing issues we face today.”
See the full list of ICAS winners here.
Other Quoted
Climate Diaries Cannes Lions 2026
Jeffrey A. Greenbaum is featured in the 51toCarbonZero article, Climate Diaries Cannes Lions 2026, which features eleven interviews with senior leaders from across the media and advertising industry conducted at the Cannes Lions International Festival of Creativity. Read more.
August 5 2026
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
